Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone
Authors:
- Stefan D AnkerSAStefan D Anker
- Maurizio VolterraniMVMaurizio Volterrani
- Claus-Dieter PflaumCPClaus-Dieter Pflaum
- Christian J StrasburgerCSChristian J Strasburger
- Karl Josef OsterzielKOKarl Josef Osterziel
- Wolfram DoehnerWDWolfram Doehner
- Michael B RankeMRMichael B Ranke
- Philip A Poole-WilsonPPPhilip A Poole-Wilson
- Andrea GiustinaAGAndrea Giustina
- Rainer DietzRDRainer Dietz
- Andrew J.S CoatsACAndrew J.S Coats
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Growth Hormone Therapy in Critically Ill PatientsNew England Journal of Medicine, 1999
- Increased Mortality Associated with Growth Hormone Treatment in Critically Ill AdultsNew England Journal of Medicine, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathyThe Lancet, 1998
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Cardiovascular effects of GHJournal of Endocrinology, 1997
- Growth Hormone in the Treatment of Dilated CardiomyopathyNew England Journal of Medicine, 1996
- Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver diseaseHepatology, 1996
- Acquired Growth Hormone Resistance in Patients with HypercatabolismHormone Research, 1993
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987